Atlas Trials

The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

Clinical trial NCT01694966 · COMPLETED

Trial details

NCT number
NCT01694966
Sponsor
Cosmo Technologies Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2013-09-01
Primary completion
2016-10-01
Enrollment
1249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.